as well as metformin combinations Janumet and Janumet XR. The US patent (No. 7,326,708) was challenged by Mylan Pharma, now Viatris, before the US Patent and Trademark Office (USPTO), which ruled ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results